These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 32771251)
21. The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis. Wijnenga MMJ; French PJ; Dubbink HJ; Dinjens WNM; Atmodimedjo PN; Kros JM; Smits M; Gahrmann R; Rutten GJ; Verheul JB; Fleischeuer R; Dirven CMF; Vincent AJPE; van den Bent MJ Neuro Oncol; 2018 Jan; 20(1):103-112. PubMed ID: 29016833 [TBL] [Abstract][Full Text] [Related]
22. Progressive Low-Grade Glioma: Assessment of Prognostic Importance of Histologic Reassessment and MRI Findings. Narang AK; Chaichana KL; Weingart JD; Redmond KJ; Lim M; Olivi A; Quinones-Hinojosa A; Kleinberg LR World Neurosurg; 2017 Mar; 99():751-757. PubMed ID: 27108796 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of prognostic factors on survival in patients with low grade glioma. Durmaz R; Vural M; Işildi E; Coşan E; Ozkara E; Bal C; Ciftçi E; Arslantaş A; Atasoy MA Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679 [TBL] [Abstract][Full Text] [Related]
24. Is there a risk of seizures in "preventive" awake surgery for incidental diffuse low-grade gliomas? Lima GL; Duffau H J Neurosurg; 2015 Jun; 122(6):1397-405. PubMed ID: 25723301 [TBL] [Abstract][Full Text] [Related]
25. Identifying clinical risk in low grade gliomas and appropriate treatment strategies, with special emphasis on the role of surgery. Boissonneau S; Duffau H Expert Rev Anticancer Ther; 2017 Aug; 17(8):703-716. PubMed ID: 28608763 [TBL] [Abstract][Full Text] [Related]
26. Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification. Jansen E; Hamisch C; Ruess D; Heiland DH; Goldbrunner R; Ruge MI; Schnell O; Grau SJ J Neurooncol; 2019 Dec; 145(3):501-507. PubMed ID: 31621043 [TBL] [Abstract][Full Text] [Related]
27. Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article. Yordanova YN; Moritz-Gasser S; Duffau H J Neurosurg; 2011 Aug; 115(2):232-9. PubMed ID: 21548750 [TBL] [Abstract][Full Text] [Related]
28. The effect of operations in patients with recurrent diffuse low-grade glioma: A qualitative systematic review. Chang J; Wang Y; Guo R; Guo X; Lu Y; Ma W; Wang R Clin Neurol Neurosurg; 2020 Sep; 196():105973. PubMed ID: 32610264 [TBL] [Abstract][Full Text] [Related]
29. Surgical management of incidentally discovered diffusely infiltrating low-grade glioma. Opoku-Darko M; Lang ST; Artindale J; Cairncross JG; Sevick RJ; Kelly JJP J Neurosurg; 2018 Jul; 129(1):19-26. PubMed ID: 28984519 [TBL] [Abstract][Full Text] [Related]
30. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI. Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120 [TBL] [Abstract][Full Text] [Related]
32. Extent of resection in diffuse low-grade gliomas and the role of tumor molecular signature-a systematic review of the literature. Albuquerque LAF; Almeida JP; de Macêdo Filho LJM; Joaquim AF; Duffau H Neurosurg Rev; 2021 Jun; 44(3):1371-1389. PubMed ID: 32770298 [TBL] [Abstract][Full Text] [Related]
33. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients. Hickmann AK; Nadji-Ohl M; Hopf NJ J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106 [TBL] [Abstract][Full Text] [Related]
34. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas. Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263 [TBL] [Abstract][Full Text] [Related]
35. Impact of Resection on Survival of Isocitrate Dehydrogenase 1-Mutated World Health Organization Grade II Astrocytoma After Malignant Progression. Grau SJ; Hampl JA; Kohl AC; Timmer M; Duval IV; Blau T; Ruge MI; Goldbrunner RH World Neurosurg; 2017 Jul; 103():180-185. PubMed ID: 28377251 [TBL] [Abstract][Full Text] [Related]
36. Residual Tumor Volume as Best Outcome Predictor in Low Grade Glioma - A Nine-Years Near-Randomized Survey of Surgery vs. Biopsy. Roelz R; Strohmaier D; Jabbarli R; Kraeutle R; Egger K; Coenen VA; Weyerbrock A; Reinacher PC Sci Rep; 2016 Aug; 6():32286. PubMed ID: 27574036 [TBL] [Abstract][Full Text] [Related]
37. High Grade Glioma Surgery - Clinical Aspects and Prognosis. Mladenovsk M; Valkov I; Ovcharov M; Vasilev N; Duhlenski I Folia Med (Plovdiv); 2021 Feb; 63(1):35-41. PubMed ID: 33650394 [TBL] [Abstract][Full Text] [Related]
38. Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival. Eseonu CI; Eguia F; ReFaey K; Garcia O; Rodriguez FJ; Chaichana K; Quinones-Hinojosa A J Neurooncol; 2017 Aug; 134(1):65-74. PubMed ID: 28527004 [TBL] [Abstract][Full Text] [Related]
39. The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas. Yamaguchi S; Kobayashi H; Terasaka S; Ishii N; Ikeda J; Kanno H; Nishihara H; Tanaka S; Houkin K Jpn J Clin Oncol; 2012 Apr; 42(4):270-7. PubMed ID: 22399670 [TBL] [Abstract][Full Text] [Related]